Halted Cancer Drug Trials May Harm Patients: Study

Law360, New York (April 10, 2008, 12:00 AM EDT) -- Pharmaceutical companies are increasingly putting the brakes on clinical trials of new cancer drugs once good results are achieved but before possible side effects are identified, a new study has found.

The study, published Wednesday in the medical journal Annals of Oncology, determined that early termination of such trials was on the rise. Only a very small percentage of trials were stopped early due to serious adverse events.

A team of researchers led by Dr. Giovanni Apolone of the Mario Negri Institute for Pharmacological Research in...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.